GE HealthCare Technologies (GEHC) Total Non-Current Liabilities (2022 - 2026)
GE HealthCare Technologies (GEHC) reported Total Non-Current Liabilities of $24.2 billion for Q1 2026, up 8.44% on a YoY basis from $22.3 billion in Q1 2025, and little changed quarter-over-quarter from $24.2 billion in Q4 2025.
GE HealthCare Technologies (GEHC) Total Non-Current Liabilities (2022 - 2026) Analysis & Trends
GE HealthCare Technologies has reported Total Non-Current Liabilities for 5 years, with the latest figure at $24.2 billion in Q1 2026.
- For the quarter ending Q1 2026, Total Non-Current Liabilities rose 8.44% year-over-year to $24.2 billion; the trailing twelve-month figure through Mar 2026 stood at $24.2 billion (up 8.44% YoY), and the FY2025 full-year result was $24.2 billion, up 7.09% from the prior year.
- Total Non-Current Liabilities for Q1 2026 stood at $24.2 billion, roughly flat from $24.2 billion in the prior quarter.
- The five-year high for Total Non-Current Liabilities was $24.2 billion in Q4 2025, with the low at $16.3 billion in Q4 2022.
- Historically, Total Non-Current Liabilities has averaged $22.8 billion across 5 years, with a median of $23.3 billion in 2023.
- Annual changes were most pronounced in 2023 — Total Non-Current Liabilities surged 42.36% — and 2024, when it dropped 4.63%.
- GE HealthCare Technologies' Total Non-Current Liabilities stood at $16.3 billion in 2022, then surged by 42.36% to $23.3 billion in 2023, then dropped by 2.69% to $22.6 billion in 2024, then grew by 7.09% to $24.2 billion in 2025, then decreased by 0.14% to $24.2 billion in 2026.
- The last three Total Non-Current Liabilities figures came in at $24.2 billion (Q1 2026), $24.2 billion (Q4 2025), and $23.8 billion (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Total Non-Current Liabilities (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.92 Bn | 146.27 Bn | 6.27 Bn | - |
| 2 | Stryker | 119.50 Bn | 116.62 Bn | 3.81 Bn | 20.94 Bn |
| 3 | Medtronic | 102.71 Bn | 94.54 Bn | 5.76 Bn | 40.52 Bn |
| 4 | Boston Scientific | 69.72 Bn | 68.51 Bn | 3.61 Bn | 15.78 Bn |
| 5 | Edwards Lifesciences | 49.24 Bn | 45.57 Bn | 1.29 Bn | 2.44 Bn |
| 6 | GE HealthCare Technologies | 29.74 Bn | 27.67 Bn | 1.98 Bn | 24.21 Bn |
| 7 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn | 9.85 Bn |
| 8 | Dexcom | 28.96 Bn | 27.84 Bn | 750.30 Mn | 3.53 Bn |
| 9 | Steris | 20.31 Bn | 19.88 Bn | 697.10 Mn | 3.47 Bn |
| 10 | Zimmer Biomet Holdings | 17.27 Bn | 16.86 Bn | 1.51 Bn | 9.41 Bn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 24.21 Bn |
| Dec 31, 2025 | 24.25 Bn |
| Sep 30, 2025 | 23.81 Bn |
| Jun 30, 2025 | 23.54 Bn |
| Mar 31, 2025 | 22.33 Bn |
| Dec 31, 2024 | 22.64 Bn |
| Sep 30, 2024 | 23.42 Bn |
| Jun 30, 2024 | 22.06 Bn |
| Mar 31, 2024 | 22.80 Bn |
| Dec 31, 2023 | 23.27 Bn |
| Sep 30, 2023 | 23.25 Bn |
| Jun 30, 2023 | 23.06 Bn |
| Mar 31, 2023 | 23.91 Bn |
| Dec 31, 2022 | 16.34 Bn |